EU Sunscreens Offer Broader Protection, Citing US Regulatory Lag
European sunscreens, regulated as cosmetics, use more diverse ingredients for superior UVA/UVB protection compared to US sunscreens, which are classified as drugs. Dermatologists suggest the US FDA's lengthy approval process hinders innovation, potentially impacting skin cancer rates, while European products are noted for better texture and longevity.
Key points
- European sunscreens are regulated as cosmetics, allowing for quicker approval of a wider range of active ingredients.
- US sunscreens are classified as drugs, subjecting new ingredients to a lengthy and costly FDA approval process.
- Dermatologists contend that this regulatory difference leads to European products offering superior UVA and UVB protection.
- European formulations are also described as less oily, less chalky, and longer-lasting than many US counterparts.
- Critics suggest the FDA's delay may contribute to rising skin cancer rates in the US by limiting access to advanced sun protection.
European sunscreens are increasingly being favored by consumers, including Americans traveling abroad, due to perceived superior protection against the sun's harmful ultraviolet rays. This difference is largely attributed to regulatory frameworks in the European Union and the United States.
In the EU, sunscreens are classified and regulated as cosmetic products. This categorization allows for greater flexibility and a faster approval process for new active ingredients. Consequently, European manufacturers can incorporate a broader spectrum of ingredients that offer enhanced defense against both UVA and UVB radiation. Many dermatologists suggest this leads to more effective sun protection compared to products available in the US.
Conversely, in the United States, sunscreens are regulated as drugs by the Food and Drug Administration (FDA). This classification mandates a more rigorous, time-consuming, and expensive approval pathway for any new sunscreen ingredients. Critics argue that this lengthy process stifles innovation and delays the availability of advanced sun protection technologies to American consumers, potentially exacerbating skin cancer concerns. Beyond efficacy, European sunscreens are often noted for their more desirable cosmetic properties, such as being less oily, less chalky, and providing longer-lasting protection.
Sources
The WireByte editorial team synthesises technology news from multiple primary sources, verifies the facts, and links every source. Articles are produced with AI assistance and reviewed under our editorial policy.